Time to Dump Micron? SK hynix to Begin Trading on Nasdaq July 10
1 min readAnalysis by AlgoThesis Editorial Desk
Market Memory
What changed after the headline
The original read stays visible beside later evidence. Connections are editorial records, not ticker-only guesses.
Price since this story
Equal-weight basket · first close after publication
Price context does not establish that the story caused the move.
The story
SK hynix, the South Korean memory giant and HBM market leader, is set to begin trading on Nasdaq on July 10, creating the first apples-to-apples U.S.-listed comparison point against Micron (MU) in the high-bandwidth memory and DRAM space. Previously accessible only via ADR or Korean exchange, hynix's Nasdaq listing removes the friction that kept many U.S. institutional investors from directly owning the name.
The competitive context matters: SK hynix has been widely cited as the dominant supplier of HBM3E to Nvidia, holding a meaningful lead over Micron in that segment. Micron's own revenue base grew 48.9% YoY to $37.4B with solid margins (39.8% gross, 22.8% net), but the HBM share story has been a persistent overhang on how aggressively the street will push MU's multiple.
The direct listing creates a relative-value setup: if SK hynix trades at a discount to MU on equivalent memory revenue metrics, that validates MU's premium; if hynix trades at parity or above, MU holders face multiple compression pressure as capital rotates toward the perceived HBM leader. Watch hynix's first-day price action and how its implied valuation compares to MU's market cap per dollar of memory revenue.
The near-term catalyst is sharp and dated — July 10 — making this a tactical watch into the listing open rather than a structural long or short thesis. The longer-term question is whether institutional rebalancing out of MU and into hynix becomes a flow story over the weeks following the listing.
The two-sided take
The house read
Two-sidedWrong ifIf hynix lists at a steep discount to MU — reflecting Korean corporate governance discount, FX risk, or limited float — the rotation thesis fails and MU could actually re-rate higher on comparative quality. Also, any positive MU-specific catalyst (new HBM win announcement, guidance raise) into the listing date kills the short leg.
Published read · research, not advice
